xCT, not just an amino-acid transporter: A multi-functional regulator of microbial infection and associated diseases

Frontiers in Microbiology

Volumn 6, Issue FEB, 2015, Pages

  Dai, Lu ^a,b   Noverr, Mairi C ^c   Parsons, Chris ^b   Kaleeba, Johnan A R ^d   Qin, Zhiqiang ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Bacteria; Cysteine; Glutamate; KSHV; Virus; XCT

Indexed keywords

AMINO ACID TRANSPORTER; BETA INTEGRIN; CD147 ANTIGEN; CD98 ANTIGEN; CISPLATIN; CYSTINE; DOXORUBICIN; GLUTAMIC ACID; GLUTATHIONE; HERPESVIRUS ENTRY MEDIATOR; LATENCY ASSOCIATED NUCLEAR ANTIGEN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; SALAZOSULFAPYRIDINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BACTERIAL INFECTION; BURKITT LYMPHOMA; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIMARY EFFUSION LYMPHOMA; PROTEIN EXPRESSION; RETINOPATHY; SHORT SURVEY; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS SURVIVAL;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 8;

EID: 84927557321     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00120     Document Type: Short Survey

References (68)

1. Akula, S. M., Naranatt, P. P., Walia, N. S., Wang, F. Z., Fegley, B., and Chandran, B. (2003). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 77, 7978-7990. doi: 10.1128/JVI.77.14.7978-7990.2003.
2. Bannai, S. (1986). Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256-2263.
3. Bannai, S., and Kitamura, E. (1980). Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255, 2372-2376.
4. Bridges, C. C., Hu, H., Miyauchi, S., Siddaramappa, U. N., Ganapathy, M. E., Ignatowicz, L., et al. (2004). Induction of cystine-glutamate transporter xc-by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 45, 2906-2914. doi: 10.1167/iovs.03-1355.
5. Butler, N. J., and Thorne, J. E. (2012). Current status of HIV infection and ocular disease. Curr. Opin. Ophthalmol. 23, 517-522. doi: 10.1097/ICU.0b013e328358ba85.
6. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191. doi: 10.1056/NEJM199505043321802.
7. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869. doi: 10.1126/science.7997879.
8. Chen, Y. B., Rahemtullah, A., and Hochberg, E. (2007). Primary effusion lymphoma. Oncologist 12, 569-576. doi: 10.1634/theoncologist.12-5-569.
9. Choi, D. W. (1987). Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369-379.
10. Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y., et al. (2005). Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 25, 7101-7110. doi: 10.1523/JNEUROSCI.5258-04.2005.
11. Dai, L., Cao, Y., Chen, Y., Parsons, C., and Qin, Z. (2014a). Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J. Hematol. Oncol. 7, 30. doi: 10.1186/1756-8722-7-30.
12. Dai, L., Defee, M. R., Cao, Y., Wen, J., Wen, X., Noverr, M. C., et al. (2014b). Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells. PLoS ONE 9:e101326. doi: 10.1371/journal.pone.0101326.
13. Dai, L., Trillo-Tinoco, J., Bai, L., Kang, B., Xu, Z., Wen, X., et al. (2014c). Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL). PLoS ONE 9:e90349. doi: 10.1371/journal.pone.0090349.
14. Dai, L., Qin, Z., Defee, M., Toole, B. P., Kirkwood, K. L., and Parsons, C. (2012). Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Lett. 318, 214-220. doi: 10.1016/j.canlet.2011.12.019.
15. de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., et al. (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13, 607-615. doi: 10.1016/S1470-2045(12)70137-7.
16. Dezube, B. J., Zambela, M., Sage, D. R., Wang, J. F., and Fingeroth, J. D. (2002). Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: early events. Blood 100, 888-896. doi: 10.1182/blood.V100.3.888.
17. Dollery, S. J., Santiago-Crespo, R. J., Kardava, L., Moir, S., and Berger, E. A. (2014). Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus. J. Virol. 88, 1748-1757. doi: 10.1128/JVI.03063-13.
18. Doxsee, D. W., Gout, P. W., Kurita, T., Lo, M., Buckley, A. R., Wang, Y., et al. (2007). Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate 67, 162-171. doi: 10.1002/pros.20508.
19. Filipits, M., Pohl, G., Rudas, M., Dietze, O., Lax, S., Grill, R., et al. (2005). Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J. Clin. Oncol. 23, 1161-1168. doi: 10.1200/JCO.2005.03.033.
20. Fried, B., Reddy, A., and Mayer, D. (2011). Helminths in human carcinogenesis. Cancer Lett. 305, 239-249. doi: 10.1016/j.canlet.2010.07.008.
21. Garrigues, H. J., Demaster, L. K., Rubinchikova, Y. E., and Rose, T. M. (2014). KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate. Virology 464-465, 118-133. doi: 10.1016/j.virol.2014.06.035.
22. Gout, P. W., Buckley, A. R., Simms, C. R., and Bruchovsky, N. (2001). Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc-cystine transporter: a new action for an old drug. Leukemia 15, 1633-1640. doi: 10.1038/sj.leu.2402238.
23. Greene, W., and Gao, S. J. (2009). Actin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cells. PLoS Pathog. 5:e1000512. doi: 10.1371/journal.ppat.1000512.
24. Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., et al. (2011). Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett. 312, 55-61. doi: 10.1016/j.canlet.2011.07.024.
25. Gupta, S., Knight, A. G., Gupta, S., Knapp, P. E., Hauser, K. F., Keller, J. N., et al. (2010). HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter. Neurosci. Lett. 485, 233-236. doi: 10.1016/j.neulet.2010.09.019.
26. Hahn, A., Birkmann, A., Wies, E., Dorer, D., Mahr, K., Sturzl, M., et al. (2009). Kaposi's sarcoma-associated herpesvirus gH/gL: glycoprotein export and interaction with cellular receptors. J. Virol. 83, 396-407. doi: 10.1128/JVI.01170-08.
27. Haimeur, A., Deeley, R. G., and Cole, S. P. (2002). Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. J. Biol. Chem. 277, 41326-41333. doi: 10.1074/jbc.M206228200.
28. Hassman, L. M., Ellison, T. J., and Kedes, D. H. (2011). KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121, 752-768. doi: 10.1172/JCI44185.
29. Huang, Y., Dai, Z., Barbacioru, C., and Sadee, W. (2005). Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 65, 7446-7454. doi: 10.1158/0008-5472.CAN-04-4267.
30. Kaleeba, J. A., and Berger, E. A. (2006a). Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry. Virology 354, 7-14. doi: 10.1016/j.virol.2006.06.009.
31. Kaleeba, J. A., and Berger, E. A. (2006b). Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311, 1921-1924. doi: 10.1126/science.1120878.
32. Lo, M., Wang, Y. Z., and Gout, P. W. (2008). The x(c)-cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 215, 593-602. doi: 10.1002/jcp.21366.
33. Longnecker, R., and Neipel, F. (2007). "Introduction to the human gamma-herpesviruses, " in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, eds A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, and K. Yamanishi (Cambridge: Cambridge University Press).
34. Ma, Q., Cavallin, L. E., Leung, H. J., Chiozzini, C., Goldschmidt-Clermont, P. J., and Mesri, E. A. (2013). A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Antioxid. Redox. Signal. 18, 80-90. doi: 10.1089/ars.2012.4584.
35. Ma, Q., Cavallin, L. E., Yan, B., Zhu, S., Duran, E. M., Wang, H., et al. (2009). Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 106, 8683-8688. doi: 10.1073/pnas.0812688106.
36. Mallery, S. R., Pei, P., Landwehr, D. J., Clark, C. M., Bradburn, J. E., Ness, G. M., et al. (2004). Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis 25, 597-603. doi: 10.1093/carcin/bgh042.
37. Manciu, L., Chang, X. B., Buyse, F., Hou, Y. X., Gustot, A., Riordan, J. R., et al. (2003). Intermediate structural states involved in MRP1-mediated drug transport. Role of glutathione. J. Biol. Chem. 278, 3347-3356. doi: 10.1074/jbc.M207963200.
38. Mesri, E. A., Feitelson, M. A., and Munger, K. (2014). Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe 15, 266-282. doi: 10.1016/j.chom.2014.02.011.
39. Myoung, J., and Ganem, D. (2011). Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 413, 1-11. doi: 10.1016/j.virol.2010.12.036.
40. Nabeyama, A., Kurita, A., Asano, K., Miyake, Y., Yasuda, T., Miura, I., et al. (2010). xCT deficiency accelerates chemically induced tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 6436-6441. doi: 10.1073/pnas.0912827107.
41. Nagasawa, K., Ito, S., Kakuda, T., Nagai, K., Tamai, I., Tsuji, A., et al. (2005). Transport mechanism for aluminum citrate at the blood-brain barrier: kinetic evidence implies involvement of system Xc-in immortalized rat brain endothelial cells. Toxicol. Lett. 155, 289-296. doi: 10.1016/j.toxlet.2004.10.004.
42. Narang, V. S., Pauletti, G. M., Gout, P. W., Buckley, D. J., and Buckley, A. R. (2003). Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer. Res. 23, 4571-4579.
43. Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., et al. (2003). Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br. J. Cancer 88, 951-956. doi: 10.1038/sj.bjc.6600786.
44. Pallis, A. G., and Syrigos, K. N. (2013). Lung cancer in never smokers: disease characteristics and risk factors. Crit. Rev. Oncol. Hematol. 88, 494-503. doi: 10.1016/j.critrevonc.2013.06.011.
45. Pang, X., Panee, J., Liu, X., Berry, M. J., Chang, S. L., and Chang, L. (2013). Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration. J. Neuroimmune Pharmacol. 8, 691-704. doi: 10.1007/s11481-013-9454-8.
46. Park, J. Y., Von Karsa, L., and Herrero, R. (2014). Prevention strategies for gastric cancer: a global perspective. Clin. Endosc. 47, 478-489. doi: 10.5946/ce.2014.47.6.478.
47. Patel, S. A., Warren, B. A., Rhoderick, J. F., and Bridges, R. J. (2004). Differentiation of substrate and non-substrate inhibitors of transport system xc-: an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology 46, 273-284. doi: 10.1016/j.neuropharm.2003.08.006.
48. Pertel, P. E. (2002). Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J. Virol. 76, 4390-4400. doi: 10.1128/JVI.76.9.4390-4400.2002.
49. Qin, S., Colin, C., Hinners, I., Gervais, A., Cheret, C., and Mallat, M. (2006). System Xc-and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-β peptide 1-40. J. Neurosci. 26, 3345-3356. doi: 10.1523/JNEUROSCI.5186-05.2006.
50. Qin, Z., Dai, L., Bratoeva, M., Slomiany, M. G., Toole, B. P., and Parsons, C. (2011). Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia 25, 1598-1609. doi: 10.1038/leu.2011.144.
51. Qin, Z., Dai, L., Defee, M., Findlay, V. J., Watson, D. K., Toole, B. P., et al. (2013). Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. J. Virol. 87, 621-635. doi: 10.1128/JVI.01441-12.
52. Qin, Z., Dai, L., Slomiany, M. G., Toole, B. P., and Parsons, C. (2010a). Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res. 70, 3884-3889. doi: 10.1158/0008-5472.CAN-09-4663.
53. Qin, Z., Freitas, E., Sullivan, R., Mohan, S., Bacelieri, R., Branch, D., et al. (2010b). Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 6:e1000742. doi: 10.1371/journal.ppat.1000742.
54. Rappocciolo, G., Hensler, H. R., Jais, M., Reinhart, T. A., Pegu, A., Jenkins, F. J., et al. (2008). Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 82, 4793-4806. doi: 10.1128/JVI.01587-07.
55. Robe, P. A., Martin, D., Albert, A., Deprez, M., Chariot, A., and Bours, V. (2006). A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. BMC Cancer 6:29. doi: 10.1186/1471-2407-6-29.
56. Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., et al. (2002). Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277, 44765-44771. doi: 10.1074/jbc.M208704200.
57. Sato, H., Fujiwara, K., Sagara, J., and Bannai, S. (1995). Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem. J. 310, 547-551.
58. Sato, H., Kuriyama-Matsumura, K., Hashimoto, T., Sasaki, H., Wang, H., Ishii, T., et al. (2001). Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J. Biol. Chem. 276, 10407-10412. doi: 10.1074/jbc.M007216200.
59. Sontheimer, H., and Bridges, R. J. (2012). Sulfasalazine for brain cancer fits. Expert. Opin. Investig. Drugs 21, 575-578. doi: 10.1517/13543784.2012.670634.
60. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
61. Taguchi, K., Tamba, M., Bannai, S., and Sato, H. (2007). Induction of cystine/glutamate transporter in bacterial lipopolysaccharide induced endotoxemia in mice. J. Inflamm. (Lond) 4, 20. doi: 10.1186/1476-9255-4-20.
62. Veettil, M. V., Bandyopadhyay, C., Dutta, D., and Chandran, B. (2014). Interaction of KSHV with host cell surface receptors and cell entry. Viruses 6, 4024-4046. doi: 10.3390/v6104024.
63. Veettil, M. V., Sadagopan, S., Sharma-Walia, N., Wang, F. Z., Raghu, H., Varga, L., et al. (2008). Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (αVβ5, αVβ3, and α3β1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J. Virol. 82, 12126-12144. doi: 10.1128/JVI.01146-08.
64. Xu, D., and Hemler, M. E. (2005). Metabolic activation-related CD147-CD98 complex. Mol. Cell. Proteomics 4, 1061-1071. doi: 10.1074/mcp.M400207-MCP200.
65. Yang, H., Zou, W., Li, Y., Chen, B., and Xin, X. (2007). Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells. Cancer Biol. Ther. 6, 942-947. doi: 10.4161/cbt.6.6.4190.
66. Yang, P., Ebbert, J. O., Sun, Z., and Weinshilboum, R. M. (2006). Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review. J. Clin. Oncol. 24, 1761-1769. doi: 10.1200/JCO.2005.02.7110.
67. Zeng, Y., Li, Y., Chen, R. S., He, X., Yang, L., and Li, W. (2010). Overexpression of xCT induces up-regulation of 14-3-3β in Kaposi's sarcoma. Biosci. Rep. 30, 277-283. doi: 10.1042/BSR20090163.
68. Zou, W., Yang, H., Hou, X., Zhang, W., Chen, B., and Xin, X. (2007). Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett. 248, 211-218. doi: 10.1016/j.canlet.2006.07.005.